{
    "drug_name_en": "heparin",
    "side_effects": {
        "Cardiovascular": {
            "Postmarketing reports": [
                [
                    "hemorrhage",
                    "retroperitoneal hemorrhage"
                ]
            ]
        },
        "Hematologic": {
            "Very common": [
                [
                    "thrombocytopenia(up to 30%)"
                ]
            ],
            "Frequency not reported": [
                [
                    "plasma lipoprotein lipase increased"
                ]
            ],
            "Postmarketing reports": [
                [
                    "heparin resistance"
                ]
            ]
        },
        "Hypersensitivity": {
            "Frequency not reported": [
                [
                    "conjunctivitis",
                    "cyanosis",
                    "tachypnea",
                    "feeling of oppression",
                    "angioneurotic edema",
                    "anaphylactic shock"
                ]
            ],
            "Postmarketing reports": [
                [
                    "chills",
                    "fever",
                    "urticaria",
                    "asthma",
                    "rhinitis",
                    "lacrimation",
                    "headache",
                    "nausea",
                    "vomiting",
                    "anaphylactoid reactions",
                    "shock",
                    "itching",
                    "burning"
                ]
            ]
        },
        "Local": {
            "Frequency not reported": [
                [
                    "erythematous nodules",
                    "infiltrated and sometimes eczema-like plaques"
                ]
            ],
            "Postmarketing reports": [
                [
                    "local irritation",
                    "erythema",
                    "mild pain",
                    "hematoma",
                    "ulceration",
                    "histamine-like reactions",
                    "skin necrosis"
                ]
            ]
        },
        "Immunologic": {
            "Frequency not reported": [
                [
                    "allergic reactions",
                    "hypereosinophilia"
                ]
            ],
            "Postmarketing reports": [
                [
                    "heparin-induced thrombocytopenia",
                    "heparin-induced thrombocytopenia and thrombosis",
                    "generalized hypersensitivity reactions"
                ]
            ]
        },
        "Endocrine": {
            "Frequency not reported": [
                [
                    "hypoaldosteronism"
                ]
            ],
            "Postmarketing reports": [
                [
                    "adrenal hemorrhage",
                    "acute adrenal insufficiency",
                    "fatal adrenal hemorrhage",
                    "aldosterone synthesis suppressed"
                ]
            ]
        },
        "Metabolic": {
            "Frequency not reported": [
                [
                    "plasma potassium increased",
                    "hyperkalemia",
                    "metabolic acidosis"
                ]
            ],
            "Postmarketing reports": [
                [
                    "reboundhyperlipidemia"
                ]
            ]
        },
        "Musculoskeletal": {
            "Frequency not reported": [
                [
                    "significant bone demineralization",
                    "spontaneousbone fracture"
                ]
            ],
            "Postmarketing reports": [
                [
                    "osteoporosis"
                ]
            ]
        },
        "Dermatologic": {
            "Frequency not reported": [
                [
                    "ecchymoses"
                ]
            ],
            "Postmarketing reports": [
                [
                    "cutaneous necrosis",
                    "delayed transientalopecia"
                ]
            ]
        },
        "Hepatic": {
            "Frequency not reported": [
                [
                    "serum transaminases increased"
                ]
            ],
            "Postmarketing reports": [
                [
                    "alt elevated significantly",
                    "ast elevated significantly"
                ]
            ]
        },
        "Genitourinary": {
            "Postmarketing reports": [
                [
                    "ovarian hemorrhage",
                    "priapism"
                ]
            ]
        },
        "Renal": {
            "Frequency not reported": [
                [
                    "renal function suppression"
                ]
            ]
        }
    }
}